Wave Life Sciences: WVE-007 Data Leaves Biotech Shaken And Stirred (Downgrade)
Source: SeekingAlpha
2026-03-26 16:27:19 ET
Investment Overview: Wave Life Stock Tumbles On Obesity Data Release
The stock of Wave Life Sciences Ltd. ( WVE ) is down >50% so far today, trading at a value of ~$6 at the time of writing (market cap of $1.2bn), after the Singapore headquartered biotech reported "positive" interim data from its INLIGHT study evaluating WVE-007, an investigational INHBE GalNAc-siRNA (SpiNA design), in otherwise healthy individuals living with overweight or obesity....
Read the full article on Seeking Alpha
For further details see:
Wave Life Sciences: WVE-007 Data Leaves Biotech Shaken And Stirred (Downgrade)
Sarepta Therapeutics Inc.
NASDAQ: SRPT
SRPT Trading
-3.59% G/L:
$22.58 Last:
637,031 Volume:
$22.65 Open:
SRPT Latest News
March 25, 2026 08:05:00 am
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 24, 2026 04:05:00 pm
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
SRPT Stock Data
$1,921,797,010
96,823,361
N/A
132
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
